₹34
(Inclusive of all Taxes)
₹5.1 Cashback (15%)
Prescription drugWhats That
Composition :
ADRENALINE-0.01MG + LIDOCAINE-21.3MG
Manufacturer/Marketer :
Celon Laboratories Pvt Ltd
Consume Type :
PARENTERAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
LidocaineArbutamine
Critical
LidocaineSaquinavir
Critical
Drug-Drug Interactions
Login/Sign Up
LidocaineArbutamine
Critical
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml and Arbutamine together can affect the rhythm of your heart.
How to manage the interaction:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with arbutamine is not recommended, but can be taken together if prescribed by a doctor. However, consult your doctor if you experience irregular heartbeat, chest tightness, blurred vision and nausea. Do not discontinue any medication without consulting a doctor.
Taking CIGNOKEN ADR 2%W/V Injection 30 ml and Arbutamine together can affect the rhythm of your heart.
How to manage the interaction:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with arbutamine is not recommended, but can be taken together if prescribed by a doctor. However, consult your doctor if you experience irregular heartbeat, chest tightness, blurred vision and nausea. Do not discontinue any medication without consulting a doctor.
LidocaineSaquinavir
Critical
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Saquinavir can increase the blood levels of CIGNOKEN ADR 2%W/V Injection 30 ml and cause an irregular heart rhythm.
How to manage the interaction:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Saquinavir is not recommended, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting and rapid heartbeat. Do not discontinue any medications without consulting a doctor.
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Saquinavir can increase the blood levels of CIGNOKEN ADR 2%W/V Injection 30 ml and cause an irregular heart rhythm.
How to manage the interaction:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Saquinavir is not recommended, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting and rapid heartbeat. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Coadministration of Ifosfamide with CIGNOKEN ADR 2%W/V Injection 30 ml can increase the risk of methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
There may be a possibility of interaction between Ifosfamide and CIGNOKEN ADR 2%W/V Injection 30 ml, but it can be taken if prescribed by a doctor. However, consult the doctor immediately if you develop gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without consulting doctor.
Coadministration of Ifosfamide with CIGNOKEN ADR 2%W/V Injection 30 ml can increase the risk of methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
There may be a possibility of interaction between Ifosfamide and CIGNOKEN ADR 2%W/V Injection 30 ml, but it can be taken if prescribed by a doctor. However, consult the doctor immediately if you develop gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without consulting doctor.
Severe
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Sulfadiazine may cause methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Co-administration of CIGNOKEN ADR 2%W/V Injection 30 ml with Sulfadiazine can possibly result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you develop gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, weakness, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without consulting doctor.
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Sulfadiazine may cause methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Co-administration of CIGNOKEN ADR 2%W/V Injection 30 ml with Sulfadiazine can possibly result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you develop gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, weakness, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without consulting doctor.
Severe
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking Rasburicase with CIGNOKEN ADR 2%W/V Injection 30 ml can increase the risk of methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Co-administration of Rasburicase with CIGNOKEN ADR 2%W/V Injection 30 ml can possibly result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you develop gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, weakness, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without consulting doctor.
Taking Rasburicase with CIGNOKEN ADR 2%W/V Injection 30 ml can increase the risk of methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Co-administration of Rasburicase with CIGNOKEN ADR 2%W/V Injection 30 ml can possibly result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you develop gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, weakness, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without consulting doctor.
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with bupropion can increase the risk of seizures(fits).
How to manage the interaction:
Co-administration of bupropion along with CIGNOKEN ADR 2%W/V Injection 30 ml can lead to an interaction, it can be taken if recommended by a doctor. In case you experience any unusual side effects, consult a doctor. Do not discontinue any medications without consulting a doctor.
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with bupropion can increase the risk of seizures(fits).
How to manage the interaction:
Co-administration of bupropion along with CIGNOKEN ADR 2%W/V Injection 30 ml can lead to an interaction, it can be taken if recommended by a doctor. In case you experience any unusual side effects, consult a doctor. Do not discontinue any medications without consulting a doctor.
LidocaineIomeprol
Severe
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml and Iomeprol may increase the risk of causing seizures(fits).
How to manage the interaction:
There may be a possibility of interaction between CIGNOKEN ADR 2%W/V Injection 30 ml and Iomeprol, but it can be taken if prescribed by a doctor. However, if you experience any unusual symptoms contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Taking CIGNOKEN ADR 2%W/V Injection 30 ml and Iomeprol may increase the risk of causing seizures(fits).
How to manage the interaction:
There may be a possibility of interaction between CIGNOKEN ADR 2%W/V Injection 30 ml and Iomeprol, but it can be taken if prescribed by a doctor. However, if you experience any unusual symptoms contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Cyclophosphamide may increase the risk of methemoglobinemia (a rare condition that can lead to oxygen deprivation in tissues and vital organs due to reduced oxygen-carrying capacity of the blood).
How to manage the interaction:
Although there is a possible interaction, cyclophosphamide can be taken with CIGNOKEN ADR 2%W/V Injection 30 ml if prescribed by the doctor. However, consult the doctor if you experience gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, weakness, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not discontinue the medication without consulting a doctor.
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Cyclophosphamide may increase the risk of methemoglobinemia (a rare condition that can lead to oxygen deprivation in tissues and vital organs due to reduced oxygen-carrying capacity of the blood).
How to manage the interaction:
Although there is a possible interaction, cyclophosphamide can be taken with CIGNOKEN ADR 2%W/V Injection 30 ml if prescribed by the doctor. However, consult the doctor if you experience gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, weakness, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not discontinue the medication without consulting a doctor.
LidocaineDofetilide
Severe
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml together with Dofetilide can increase the risk of an irregular heart rhythm and other side effects.
How to manage the interaction:
There may be a possibility of interaction between CIGNOKEN ADR 2%W/V Injection 30 ml and Dofetilide, but it can be taken if prescribed by a doctor. However, consult the doctor immediately if you experience symptoms such as dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations. Do not discontinue any medications without first consulting your doctor.
Taking CIGNOKEN ADR 2%W/V Injection 30 ml together with Dofetilide can increase the risk of an irregular heart rhythm and other side effects.
How to manage the interaction:
There may be a possibility of interaction between CIGNOKEN ADR 2%W/V Injection 30 ml and Dofetilide, but it can be taken if prescribed by a doctor. However, consult the doctor immediately if you experience symptoms such as dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations. Do not discontinue any medications without first consulting your doctor.
LidocainePrilocaine
Severe
How does the drug interact with CIGNOKEN ADR 2%W/V Injection 30 ml:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Prilocaine may cause methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Prilocaine together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you develop gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, weakness, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without consulting doctor.
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Prilocaine may cause methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Taking CIGNOKEN ADR 2%W/V Injection 30 ml with Prilocaine together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you develop gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, weakness, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without consulting doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Author Details
Drug-Diseases Interactions
No Drug - Disease interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Diseases Interactions
Login/Sign Up
Have a query?
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking Cignoken ADR 2% Injection. Alcohol intake, along with Cignoken ADR 2% Injection, may cause increased drowsiness.
Pregnancy
Unsafe
It is not recommended to take Cignoken ADR 2% Injection while you are pregnant. Please consult your doctor if you have any concerns regarding this, your doctor will prescribe you Cignoken ADR 2% Injection only if the benefits outweigh the risks.
Breast Feeding
Unsafe
Please consult your doctor if you have any concerns regarding this, your doctor will decide whether breastfeeding mothers can take Cignoken ADR 2% Injection or not.
Driving
Caution
Cignoken ADR 2% Injection may cause drowsiness and vision disturbances, do not drive or operate heavy machinery if you feel drowsy.
Liver
Caution
Cignoken ADR 2% Injection should be used with caution in patients with liver impairment/liver disease. Dose adjustment may be needed. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Cignoken ADR 2% Injection should be used with caution in patients with kidney impairment/kidney disease. Dose adjustment may be needed. Please consult your doctor if you have kidney impairment or any concerns regarding this.
Children
Unsafe
Cignoken ADR 2% Injection should not be used by children, as the efficacy and safety have not been established.
